The effects of Implanon® on menstrual bleeding patterns

References

• d'Arcangues C, Odlind V, Fraser I S. Dysfunctional uterine bleeding induced by exogenous hormones. Presented at Steroid Hormones and Uterine Bleeding: Meeting on the Effects of Steroid Hormones and Endometrial Vasculature, Bethesda, MD, 1992
   Google Scholar
• Belsey E M. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 1988; 38: 207–25
   PubMed Web of Science ®Google Scholar
• Fraser I S, Weisberg E, Minehan E, et al. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Contraception 2000; 61: 241–51
   PubMed Web of Science ®Google Scholar
• Livingstone M, Fraser I S. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002; 8: 60–67
   PubMed Web of Science ®Google Scholar
• Hickey M, d'Arcangues C. Vaginal bleeding disturbances and implantable contraceptives. Contraception 2002; 65: 75–84
   PubMed Web of Science ®Google Scholar
• Funk S, Miller M M, Mishell D R, Jr., et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005; 71: 319–26
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Belsey E M, Farley T M. The analysis of menstrual bleeding patterns: A review. Contraception 1988; 38: 129–56
   PubMed Web of Science ®Google Scholar
• Belsey E M, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986; 34: 253–60
   PubMed Web of Science ®Google Scholar
• Fraser I S. Bleeding arising from the use of exogenous steroids. Baillieres Best Pract Res Clin Obstet Gynaecol 1999; 13: 203–22
   PubMed Web of Science ®Google Scholar
• Belsey E M, Pinol A P. Menstrual bleeding patterns in untreated women. Task force on long-acting systemic agents for fertility regulation. Contraception 1997; 55: 57–65
   PubMed Web of Science ®Google Scholar
• Treloar A E, Boynton R E, Behn B G, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967; 12: 77–126
   PubMedGoogle Scholar
• Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 1994; 49: 56–72
   PubMed Web of Science ®Google Scholar
• Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: A multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994; 61: 70–77
   PubMed Web of Science ®Google Scholar
• Belsey E M, Peregoudov S. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations. Contraception 1988; 38: 227–42
   PubMed Web of Science ®Google Scholar
• Magalhaes J, Aldrighi J M, de Lima G R. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007; 75: 193–8
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception: The effective and appropriate use of long-acting reversible contraception. National Institute for Health and Clinical Excellence, LondonUK October, 2005
   Google Scholar
• Belsey E M. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 1988; 38: 181–206
   PubMed Web of Science ®Google Scholar
• Archer D F, Jensen J T, Johnson J V, et al. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: Phase 3 study results. Contraception 2006; 74: 439–45
   PubMed Web of Science ®Google Scholar
• Grow D R. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 2002; 29: 425–36
   PubMed Web of Science ®Google Scholar
• Belsey E M, d'Arcangues C, Carlson N. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics. Contraception 1988; 38: 243–57
   PubMed Web of Science ®Google Scholar
• Vincent A J, Salamonsen L A. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 2000; 15: 135–43
   PubMed Web of Science ®Google Scholar
• Mascarenhas L, van Beek A, Bennink H C, et al. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK. Hum Reprod 1998; 13: 3057–60
   PubMed Web of Science ®Google Scholar
• Charnock-Jones D S, Macpherson A M, Archer D F, et al. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 2000; 15: 85–95
   PubMed Web of Science ®Google Scholar
• Van den Bosch T, Donders G G, Riphagen I, et al. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant. Ultrasound Obstet Gynecol 2002; 20: 377–80
   PubMed Web of Science ®Google Scholar
• Abdel-Aleem H, d'Arcangues C, Vogelsong K, et al. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2007, CD003449
   Web of Science ®Google Scholar
• Alvarez-Sanchez F, Brache V, Thevenin F, et al. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996; 174: 919–22
   PubMed Web of Science ®Google Scholar
• Diaz S, Croxatto H B, Pavez M, et al. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990; 42: 97–109
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhu H, Wang A, et al. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000; 15: 1969–72
   PubMed Web of Science ®Google Scholar
• Verbost P M, Hanssen R G, Korver G H, et al. ORG 33628 and ORG 31710 to control vaginal bleeding in progestin-only contraceptive regimens. Semin Reprod Med 2005; 23: 101–11
   PubMed Web of Science ®Google Scholar
• Weisberg E, Hickey M, Palmer D, et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006; 21: 295–302
   PubMed Web of Science ®Google Scholar
• Abdel-Aleem H, Shaaban O M, Amin A F, et al. Tamoxifen treatment of bleeding irregularities associated with Norplant use. Contraception 2005; 72: 432–7
   PubMed Web of Science ®Google Scholar
• d'Arcangues C, Piaggio G, Brache V, et al. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception 2004; 70: 451–62
   PubMed Web of Science ®Google Scholar